Xellar Biosystems

Xellar Biosystems pioneers AI-driven biotechnology, leveraging the power of machine-learning and human-centric data to streamline the traditionally tedious process of drug discovery. Our microfluidic 3D cell culture devices, which mimic various organs and diseases, are designed with efficiency in mind—integrating automation, scalability, and cost-effectiveness. This technology enables high-content, high-resolution images to be fed into our computational and AI pipeline, fueling a powerful and highly predictive platform. Committed to redefining biotechnology, Xellar Biosystems accelerates the journey of drug discovery, safety evaluation and personalized medicine.